medigraphic.com
SPANISH

Revista Biomédica

Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 4

<< Back Next >>

Rev Biomed 2005; 16 (4)

Specific antibody production against different life cycle stages during an experimental A. costaricensis infection in mice.

Abrahams-Sandí E, Michael Geiger S, Fernández-Quesada K, Schulz-Key H
Full text How to cite this article

Language: English
References: 54
Page: 239-246
PDF size: 113.21 Kb.


Key words:

Angiostrongylus costaricensis, antigen, antibody production, C57BL/6, ELISA.

ABSTRACT

Objectives.- In the present study we aimed at investigating the humoral immune response against different Angiostrongylus costaricensis life-cycle stages- L1, L3, eggs and adult worms- during an experimental infection in C57BL/6 mice.
Materials and Methods.- C57BL/6 mice were experimentally infected with six third- stage larvae (L3) Angiostrongylus costaricensis. Blood samples from infected mice were obtained weekly by puncture of the retroorbital venous plexus and individual sera were stored at –20°C. PBS-soluble antigen extracts from adult worm, its excretory-secretory products, L1, L3, and eggs were prepared. Fractionation of all soluble antigen preparations by SDS-PAGE was performed and the antibody production in infected mice against all antigens was monitored during 9 weeks by ELISA.
Results and Discussion.- The production of different antibody isotypes was directed against all the different antigen preparations, with a predominance of IgG1 antibodies and a significant increase of IgA antibody levels after maturation of worms and egg deposition. The highest parasite-specific IgA antibody levels were detected against E/S- and L3-antigen at 2 and 3 weeks p.i., respectively. On the other hand, the highest IgG1 antibody response was measured against E/S- and egg-antigen at 3 weeks p.i. and remained high until the end of the experiment. Values for parasite-specific IgG2a, determined by ELISA, reached only low levels against all antigen preparations. We propose further studies with human sera in order to investigate the usefulness of egg and E/S-antigen for the diagnosis of human abdominal angiostrongyliasis.


REFERENCES

  1. 1.- Morera P. Abdominal angiostrongyliasis: a problem of public health. Parasitol Today 1985; 1:173–5.

  2. 2.- World Health Organization. Prevention and control of intestinal parasitic infections. Tech Rep Ser 1987; 749:21–8.

  3. 3.- Graeff-Teixeira C, Camillo-Coura L, Lenzi HL. Angiostrongíliase abdominal nova parasitose no sul do Brasil R. AMRIGS 1991; 35:91–8.

  4. 4.- Graeff-Teixeira, C., Agostini, A.A., Camillo-Coura, L., Ferreira-Da-Cruz, M.F. Seroepidemiology of abdominal angiostrongyliasis: the standardization of an immunoenzymatic assay and prevalence of antibodies in two localities in southern Brazil. Trop Med Int Health 1997; 2: 254–60.

  5. 5.- Lawrence RA, Allen JE, Osborne J, Maizels. Adult and microfilarial stages of the filarial parasite Brugia malayi stimulate contrasting cytokine and Ig isotype responses in BALB/c mice. J Immunol 1996; 153: 1216-1224.

  6. 6.- Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A. Down regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasite helminth, Schistosoma mansoni. J Exp Med 1991; 173: 159-66.

  7. 7.- Parkhouse RME, Harrison LJS. Antigens of parasitic helminths in diagnosis, protection and pathology. Parasitology 1989; 99: S5-S19.

  8. 8.- Abrahams-Sandí E, Hoffmann WH, Graeff-Teixeira C, Schulz-Key H, Geiger SM. Long-term observations on mouse strains experimentally infected with Angiostrongylus costaricensis. Parasitol Res 2004; 93: 230-4.

  9. 9.- Geiger SM, Abrahams-Sandí E, Soboslay PT, Hoffmann WH, Pfaff AW, Graeff-Teixeira C, Schulz-Key H. Cellular immune responses and cytokine production in BALB/c and C57BL/6 mice during the acute phase of Angiostrongylus costaricensis. Acta Trop 2001; 80: 59-68.

  10. 10.- Geiger SM, Graeff-Teixeira C, Soboslay PT, Schulz-Key H. Experimental Angiostrongylus costaricensis infection in mice: immunoglobulin isotype responses and parasite-specific antigen recognition after primary low-dose infection. Parasitol Res 1999; 85: 200-5.

  11. 11.- Geiger SM, Hoffmann WH, Soboslay PT, Pfaff AW, Graeff-Teixeira C, Schulz-Key H. Angiostrongylus costaricensis infection in C57BL/6 mice: MHC-II deficiency results in increased larval elimination but unaltered mortality. Parasitol Res 2003; 90:415–20.

  12. 12.- Heukeshoven J, Dernick R. Characterization of a solvent system for separation of water-insoluble poliovirus proteins by reversed-phase high-performance liquid chromatography. J Chromatogr 1985; 326:91-101.

  13. 13.- Fujii T. Angiostrongylus cantonensis:immunoblot analysis of the antigens recognized by rats. Parasitol Res 1987; 73: 366-74.

  14. 14.- Fujii T. Immunoblot analysis of the circulating antigens occurring in serum rats infected with Angiostrongylus cantonensis. Parasitol Res 1988; 74: 476-83.

  15. 15.- Dharmkrong-AT A, Sirisinha S. Analysis of antigens from different developmental stages of A. cantonensis. Southeast Asian J Trop Med Pub Hlth 1983; 14: 154-62.

  16. 16.- Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 114: 642-6.

  17. 17.- Pritchard DI. Immunity to helminths: is too much IgE parasite-rather than host protective?. Parasite Immunol 1993; 15: 5-9.

  18. 18.- Capron M, Riveau G, Grzych JM. Development of a vaccine strategy against human and bovine schistosomiasis: Background and update. Tropical and Geographical Medicine 1994;47: 242-6.

  19. 19.- Dunne DW. The use of mouse/ human chimaeric antibodies to investigate the roles of different antibody isotype, incluiding IgA2, in the killing of Schistosoma mansoni by eosinophils. Parasite Immunol 1993; 15: 181-5.

  20. 20.- Grezel D, Capron M, Grzych JM. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanism involving IgE and IgA. Europ J Immunol 1993; 23:454-60.

  21. 21.- Atkins N S, Lindo JF, Lee MG, Conway DJ, Bailey JW, Robinson R, Bundy DAP. Humoral responses in human strongyloidiasis: correlations with infection chronicity. Trans Roy Soc Trop Med Hyg 1997; 91: 609-13.

  22. 22.- Atkins NS, Conway DJ, Lindo JF, Bailey JW, Bundy DAP. L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output. Parasite Immunol 1999; 21: 517-26.

  23. 23.- Sugaya H, Aoki M, Yoshida T, Takatsu K, Yoshimura K Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor chain-knockout mice infected with Angiostrongylus cantonensis. Parasitol Res 1997; 83: 583-90.

  24. 24.-Nacapunchai D, Ishii AI, Terada M, Kino H, Sano M. Humoral immune responses in mice infected with Angiostrongylus costaricensis. Serodiagnosis and Immunotherapy in Infectious Disease 1989; 3:51-6.

  25. 25.- Mountford AP, Fisher A, Wilson RA. The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni. Parasite Immunol 1994; 16: 521-7.

  26. 26.- Poulain-Godefroy O, Gaubert S, Lafitte S. Immunoglobulin A response in murine schistosomiasis: stimulatory role of egg antigens. Infect Immun 1996; 64: 763-8.

  27. 27.- Taverne J, Bradley JE. Immunity to protozoa and worms. En: Roitt I, Brostoff J, Male D. editores. Immunology. 5a. ed. London: Mosby-Wolfe; 1998. p. 243-60.

  28. 28.- Bender AL, Maurer RL, Fernandes da Silva MC, Ben R, Barros TP, Aramburu da Silva AC, Graeff-Teixeira C. Ovos e órgăos reprodutores de fęmeas de Angiostrongylus costaricensis săo reconhecidos mais intensamente por soros humanos de fase aguda na angiostrongilíase abdominal. Rev Soc Bras Med Trop 2003; 36: 449-54.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Biomed. 2005;16